Pharmaceutical Manufacturing & Packaging In-Depth Focus 2013

Posted: 18 February 2013 | | No comments yet

In this Pharmaceutical Manufacturing & Packaging In-Depth Focus: The chemical safety assessment process for extractables and leachables associated with packaged pharmaceutical products; INTERPHEX 2013: Show preview…

Manufacturing In-Depth Focus 2013
  • The chemical safety assessment process for extractables and leachables associated with packaged pharmaceutical products
    Dennis Jenke, Baxter Distinguished Scientist, Baxter Healthcare Corporation
    Packaged pharmaceutical drug products can interact with their packaging, resulting in the migration of substances from the packaging and into the drug product. This is of concern due to the potential toxicity and/or reactivity of the migrating substances. In order to properly assess the safety risk and manage the safety hazard posed by migratory substances, it is first necessary to establish, via the application of a rigorous and extensive chemical analysis process, the identities of the migratory substances and the levels to which they will accumulate in the finished drug product. This analytical data is then evaluated by toxicologically establishing the safety hazard posed by the migratory substances, a process by which the actual user exposure to the migrating substances is balanced against a tolerable dose calculated for each migrating substance.
  • INTERPHEX 2013: Show preview
    From 23-25 April, INTERPHEX, the largest annual industry exhibit for pharmaceutical manufacturing & biopharma manufacturers, organised by Reed Exhibitions, will open its 2013 event at New York’s Javits Center with a with a new and improved experience for 2013. This event has evolved to meet the industry’s needs, including a re-engineered conference programme, expanded product categories on the show floor and additional networking opportunities.

This Pharmaceutical Manufacturing & Packaging In-Depth Focus is restricted - login or subscribe free to access

European Pharmaceutical Review Issue 5 2022Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here